|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||25.93 - 25.93|
|52-week range||23.00 - 29.70|
|Beta (5Y monthly)||1.21|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||0.75 (2.90%)|
|Ex-dividend date||31 Mar 2021|
|1y target est||N/A|
Skanska has, as part of a joint venture with Traylor Bros., Inc., signed a contract with NJ TRANSIT to build the Portal North Bridge replacement in Hudson County, New Jersey, USA. The total contract is worth USD 1.56B. Skanska's share of the contract is worth USD 1.09B, about SEK 9.4B, which will be included in the US order bookings for the fourth quarter of 2021.
Skanska has divested a portfolio of two office projects in Wroclaw and Krakow, Poland, for EUR 128M, about SEK 1.3 billion. The buyer is Stena Real Estate BV. The transaction will be recorded by Skanska Commercial Development Europe in the first quarter of 2022. The transfer of the properties is scheduled for the second quarter of 2022.
Skanska has signed a contract with Continuus Pharmaceuticals to build a pharmaceutical manufacturing facility in Woburn, Massachusetts, USA. The contract is worth USD 125M, about SEK 1.1 billion, which will be included in the US order bookings for the fourth quarter 2021.